Analytical performance, agreement and user-friendliness of five C-reactive protein point-of-care tests

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 73, Issue 8, 2013, Pages 627-634

  Minnaard, Margaretha C ^a   Van De Pol, Alma C ^a   Broekhuizen, Berna D L ^a   Verheij, Theo J M ^a   Hopstaken, Rogier M ^b   Van Delft, Sanne ^b   Kooijman Buiting, Antoinette M J ^b   De Groot, Joris A H ^a   De Wit, Niek J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Thrombosis Service and Primary Care Diagnostic Centre Saltro   (Netherlands)

Author keywords

C reactive protein; Diagnostic reference standards; Humans; Point of care systems; Quality control; Reagent kits

Indexed keywords

C REACTIVE PROTEIN; D DIMER; HEMOGLOBIN A1C;

ANALYZER; ARTICLE; C REACTIVE PROTEIN TEST KIT; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; PERFORMANCE MEASUREMENT SYSTEM; POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE;

BLOOD CHEMICAL ANALYSIS; C-REACTIVE PROTEIN; HUMANS; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY;

EID: 84887569129     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.841985     Document Type: Article

References (32)

1. de Wit NJ, Berger MY, Vogelenzang R, Wetzels RV, van Rijn-van Kortenhof NM, OpsteltenW, Goudswaard AN. [Summary of the Dutch College of General Practitioners (NHG) practice guideline on Diverticulitisj. Ned Tijdschr Geneeskd 2012;156:A4140.
2. Verlee L, Verheij TJ, Hopstaken RM, Prins JM, Salome PL, Bindels PJ. [Summary of NHG practice guideline Acute coughj. Ned Tijdschr Geneeskd 2012; 1 56:A41 88.
3. Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 2009;338:b1374.
4. Hopstaken RM, Muris JW, Knottnerus JA, Kester AD, Rinkens PE, Dinant GJ. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 2003;53:358-64. (Pubitemid 36582092)
5. Andersson M,Andersson RE.The appendicitis inflammatory response score: a tool for the diagnosis of acute appendicitis that outperforms the Alvarado score. World J Surg 2008; 32: 1843-9.
6. Kaser SA, Fankhauser G, Glauser PM,Toia D, Maurer CA. Diagnostic value of inflammation markers in predicting perforation in acute sigmoid diverticulitis. World J Surg 2010;34: 27 17-22.
7. Engel MF, Paling FP, Hoepelman AT, van dMV, Oosterheert JJ. Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review. Fam Pract 2012;29:383-93.
8. Falk G, FaheyT. C-reactive protein and community-acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies. Fam Pract 2009;26:10-21.
9. van der Meer V, Neven AK, van den Broek PJ, Assendelft WJ. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ 2005; 33 1:26.
10. http: madox.org horizon-scanning-reports 20110017 point-of-care-test- poct-for-c-reactive-protein-crp
11. Cals JW, Ament AJ, Hood K, Butler CC, Hopstaken RM, Wassink GF, Dinant GJ. C-reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial. J Eval Clin Pract 2011;17:1059-69.
12. Dahler-Eriksen BS, Lassen JF, Petersen PH, Lund ED, Lauritzen T, Brandslund I. Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots. Clin Chem 1997; 43 :2064-75. (Pubitemid 27497804)
13. Dinant GJ, Costongs R, Leclercq RM, van Wersch JW. Reliability of C-reactive protein measurement in general practice in The Netherlands. Scand J Clin Lab Invest 1994;54:113-7. (Pubitemid 24231604)
14. Esposito S, Tremolati E, Begliatti E, Bosis 5, Gualtieri L, Principi N. Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein. Clin Chem Lab Med 2005;43:438-40. (Pubitemid 41460651)
15. Monteny M, ten Brinke MH, van Brakel J, de Rijke YB, Berger MY. Point-of-care C-reactive protein testing in febrile children in general practice. Clin Chem Lab Med 2006; 44:1428-32. (Pubitemid 44967691)
16. Seamark DA, Backhouse SN, Powell R. Field-testing and validation in a primary care setting of a point-of-care test for C-reactive protein. Ann Clin Biochem 2003;40: 178-80. (Pubitemid 36359872)
17. Urdal P, Borch SM, Landaas 5, Krutnes MB, Gogstad GO, Hjortdahl P. Rapid immunometric measurement of C- reactive protein in whole blood. Clin Chem 1992;38: 580-4.
18. Zecca E, Barone G, Corsello M, Romagnoli C, Tiberi E, Tirone C,Vento G. Reliability of two different bedside assays for C-reactive protein in newborn infants. Clin Chem Lab Med 2009;47:1081-4.
19. http: www.skup.dk 20130404 fix afproevninger ?mode liste&category 12.
20. Lippi G, Ippolito L, Russello T, Ponzo V, Salvagno GL, Guidi GC. Analytical performance of the new ACL AcuStar HemoslL D-Dimer. Blood Coagul Fibrinolysis 2012; 23:164-7.
21. Reix N, Massart C, Gasser F, Heurtault B, Agin A. Should functional sensitivity of a new thyroid stimulating hormone immunoassay be monitored routinely? The ADVIA Centaur(R) TSH3-UL assay experience. Clin Biochem 2012; 45: 1260-2.
22. Tpfer G, Lutze G, Sauer K, Friedel G, Hornig F, Kuhnert T. Einflufl der Citratkonzentration in Blutent Nahmerhrchen auf hmostaseologische Meflgrflen [Influence of the sample tubes citrate concentration on coagulation analytesj. J Lab Med 2001;25: 162-8. (Pubitemid 32612041)
23. Zhang DJ, Elswick RK, Miller WG, Bailey JL. Effect of serum-clot contact time on clinical chemistry laboratory results. Clin Chem 1998;44:1325-33. (Pubitemid 28283074)
24. Clinical and Laboratory Standards Institute (CLSI). Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS Document EP5-A. Wayne, PA: CLSI, 1992.
25. Clinical and Laboratory Standards Institute (CLSI). Method comparison and bias estimation using patient samples; approved guideline. CLSI Document EP9-A. Wayne, PA: CLSI, 1992.
26. Clark GH, Fraser CG. Biological variation of acute phase proteins. Ann Clin Biochem 1993;30:373-6. (Pubitemid 23222952)
27. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997;43:52-8. (Pubitemid 27024390)
28. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995;346:1085-7.
29. Dewitte K, Fierens C, Stockl D,Thienpont LM. Application of the Bland-Altman plot for interpretation of method- comparison studies: a critical investigation of its practice. Clin Chem 2002;48:799-801. (Pubitemid 34439125)
30. Geersing GJ, Toll DB, Janssen KJ, Oudega R, Blikman MJ, Wij land R, deVooght KM, Hoes AW, Moons KG. Diagnostic accuracy and user-friendliness of 5 point-of-care D-dimer tests for the exclusion of deep vein thrombosis. Clin Chem 2010;56: 17 58-66.
31. Hjortdahl P, Landaas 5, Urdal P, Steinbakk M, Fuglerud P, Nygaard B. C-reactive protein: a new rapid assay for managing infectious disease in primary health care. Scand J Prim Health Care 1991;9:3-10.
32. Hobbs FD, Kenkre JE, CarterYH, Thorpe GH, Holder RL. Reliability and feasibility of a near patient test for C-reactive protein in primary care. Br J Gen Pract 1996;46:395-400. (Pubitemid 26245288)